Holding(s) in Company

For filings with the FCA include the annex
For filings with issuer exclude the annex

   

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

   

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii The Biotech Growth Trust PLC

   

2 Reason for the notification (please tick the appropriate box or boxes):

   

An acquisition or disposal of voting rights Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments No
An event changing the breakdown of voting rights No
Other (please specify): No

   

3. Full name of person(s) subject to the notification obligation: iii Schroders plc
4. Full name of shareholder(s)  (if different from 3.):iv      
5. Date of the transaction and date on which the threshold is crossed or reached: v 1 October 2015
6. Date on which issuer notified: 5 October 2015
7. Threshold(s) that is/are crossed or reached: vi, vii Above 5%

8. Notified details:
A: Voting rights attached to shares
viii, ix

Class/type of
shares



if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after
the triggering
transaction

Number
of
Shares
Number
of
Voting
Rights

Number
of
shares
Number
of
voting
rights
% of voting
rightsx
Direct Direct xi Indirect xii Direct Indirect
     Ordinary
GB0000385517
Below 5% Below 5% 3,122,030 N/A 3,122,030 N/A 5.022%

   

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction

   

Type of financial
instrument
Expiration
date
xiii
Exercise/
Conversion Period
xiv
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights
                             

   

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction

   

Type of financial
instrument
Exercise
price
Expiration
date
xvii
Exercise/
Conversion
period
xviii
Number of voting
rights instrument
refers to
% of voting
rights
xix, xx
Nominal Delta
                       

   

Total (A+B+C)

   

Number of voting rights Percentage of voting rights
     3,122,030 5.022%

   

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Schroder & Co. Limited – 3,122,030 – 5.022%

   

Proxy Voting:
10. Name of the proxy holder: n/a
11. Number of voting rights proxy holder will cease to hold: n/a
12. Date on which proxy holder will cease to hold voting rights: n/a

   

13. Additional information: The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issued share capital amount 62,160,892
14. Contact name: Chloe Talbot
15. Contact telephone number: 020 7658 6000
UK 100

Latest directors dealings